HCW Biologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-24.99	-14.9	-12.86	-7.07	-7.78
Depreciation & Amortization	1.14	0.72	0.57	0.57	0.42
Share-Based Compensation	1	1.12	0.36	0.02	0
Other Operating Activities	0.34	2.68	0.95	-5.22	0.1
Operating Cash Flow	-22.51	-10.39	-10.98	-10.43	-6.77
Capital Expenditures	-6.2	-10.28	-0.05	-0.19	-1.46
Change in Investments	10	24.98	-34.97	0	0
Other Investing Activities	-	-	-	-	0
Investing Cash Flow	3.8	14.71	-35.02	-0.19	-1.46
Share Issuance / Repurchase	0.02	0.02	56.03	0.01	0.06
Debt Issued / Paid	-0.04	6.45	0	0.56	0
Other Financing Activities	-	-0.19	-6.76	11.14	13.39
Financing Cash Flow	-0.01	6.27	49.27	11.72	13.45
Net Cash Flow	-18.73	10.6	3.27	1.1	5.22
Free Cash Flow	-28.72	-20.66	-11.02	-10.62	-8.23
Free Cash Flow Margin	-5124.69%	-798.85%	-	-258.99%	-
Free Cash Flow Per Share	-0.80	-0.58	-0.59	-2.24	-1.92

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).